Robotic Bronchoscopy Revolutionizes Early Lung Cancer Detection and Treatment

A new robotic-assisted bronchoscopy system is improving the detection and treatment of lung cancer. Developed with input from the Mayo Clinic, the technology offers higher accuracy and safety compared to traditional methods. Early results show it could transform how clinicians diagnose and manage suspicious lung nodules. The system uses shape-sensing robotic tools to navigate deep into the lungs with greater precision. Clinicians can now sample multiple nodules across both lungs in a single procedure. This reduces the need for repeat interventions and improves diagnostic efficiency.

A Mayo Clinic study found the technology detects malignant growths with 85% sensitivity. When assessed under unified national criteria, its overall diagnostic accuracy reaches nearly 77%. Of the lesions sampled, 56% were confirmed malignant, while 21% were benign and 23% remained inconclusive. Safety data is equally promising. Complications occurred in just 2.8% of cases, reinforcing the procedure's low-risk profile. The system also integrates endobronchial ultrasound (EBUS), enabling accurate staging by sampling lymph nodes in the mediastinum. Beyond diagnosis, robotic bronchoscopy is being combined with treatments like pulsed electric field ablation (PEF). This allows for minimally invasive therapy of early-stage tumours. The approach could shift lung cancer care toward earlier, less aggressive interventions. In the US alone, screening programmes identify around 1.6 million suspicious lung nodules each year. While most are benign, malignant cases remain the leading cause of cancer deaths. Early detection is critical—localised lung cancer has a five-year survival rate of 67%, compared to just 12% once the disease spreads.

The technology is already in use at select medical centres, though global adoption figures are not yet tracked. Its ability to improve accuracy, reduce complications, and enable targeted treatments marks a significant step forward. For patients, this means faster diagnoses and potentially better survival outcomes.